Approvals/TGA/XULTOPHY insulin degludec 100 units/mL liraglutide 3.6 mg/mL solution for injection/pre-filled pen 3 mL

Approved

STANDARD

XULTOPHY insulin degludec 100 units/mL liraglutide 3.6 mg/mL solution for injection/pre-filled pen 3 mL

Novo Nordisk Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: bec720fc31193c0c
Product Name: XULTOPHY insulin degludec 100 units/mL liraglutide 3.6 mg/mL solution for injection/pre-filled pen 3 mL
Artg Id: 328580
Artg Name: XULTOPHY insulin degludec 100 units/mL liraglutide 3.6 mg/mL solution for injection pre-filled pen 3 mL
Sponsor: Novo Nordisk Pharmaceuticals Pty Ltd
Company Detail Path: /organization/novo-nordisk-pharmaceuticals-pty-limited
Artg Date: 2020-12-22
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

bec720fc31193c0c

Type

Standard